Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
40.5M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
+15.7K
-
Total reported value, excl. options
-
$263M
-
Value change
-
+$330K
-
Put/Call ratio
-
0.51
-
Number of buys
-
70
-
Number of sells
-
-61
-
Price
-
$13.41
Significant Holders of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) as of Q4 2022
153 filings reported holding PAHC - PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share as of Q4 2022.
PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 40.5M outstanding shares and own 48.36% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.66M shares), VANGUARD GROUP INC (2.36M shares), PZENA INVESTMENT MANAGEMENT LLC (1.97M shares), STATE STREET CORP (916K shares), ACADIAN ASSET MANAGEMENT LLC (731K shares), HEARTLAND ADVISORS INC (714K shares), BRANDES INVESTMENT PARTNERS, LP (639K shares), RENAISSANCE TECHNOLOGIES LLC (532K shares), DIMENSIONAL FUND ADVISORS LP (518K shares), and Bank of New York Mellon Corp (494K shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.